Regeneron 300 Valley View | Regeneron Pharmaceuticals | New York | local | 2021 | $119,479 | | tax credit/rebate |
Regeneron | Regeneron Pharmaceuticals | New York | local | 2021 | $121,874 | | tax credit/rebate |
Steel Forest, LLC | AbbVie | New York | local | 2021 | $261,116 | | tax credit/rebate |
Regeneron Pharmaceuticals | Regeneron Pharmaceuticals | New York | local | 2021 | $4,324,671 | | tax credit/rebate |
Bristol-Myers Squibb | Bristol-Myers Squibb | New York | local | 2021 | $390,427 | | tax credit/rebate |
Emergent Biosolutions | Emergent BioSolutions | Maryland | local | 2014 | $250,000 | | infrastructure assistance |
Allergan Inc. | AbbVie | Texas | local | 2012 | undisclosed | | grant |
Regeneron Building D | Regeneron Pharmaceuticals | New York | local | 2022 | $2,171,758 | | tax credit/rebate |
Bristol-Myers Squibb | Bristol-Myers Squibb | New York | local | 2022 | $336,050 | | tax credit/rebate |
Steel Forest, LLC | AbbVie | New York | local | 2022 | $264,555 | | tax credit/rebate |
Amneal (50 Horseblock-NM AMNL) | Amneal Pharmaceuticals | New York | local | 2022 | $226,608 | | tax credit/rebate |
Amneal Pharmaceuticals LLC 2019 Facility | Amneal Pharmaceuticals | New York | local | 2022 | $169,333 | | tax credit/rebate |
Regeneron Pharmaceuticals | Regeneron Pharmaceuticals | New York | local | 2022 | $133,565 | | tax credit/rebate |
Bausch & Lomb Incorporated | Bausch Health | New York | local | 2022 | $116,856 | | tax credit/rebate |
Regeneron | Regeneron Pharmaceuticals | New York | local | 2022 | $113,118 | | tax credit/rebate |
Bausch & Lomb Incorporated | Bausch Health | New York | local | 2022 | $75,893 | | tax credit/rebate |
Regeneron Phase II (aka LOOP Road project) | Regeneron Pharmaceuticals | New York | local | 2022 | $74,201 | | tax credit/rebate |
Regeneron | Regeneron Pharmaceuticals | New York | local | 2022 | $63,375 | | tax credit/rebate |
Regeneron Pharmaceuticals II | Regeneron Pharmaceuticals | New York | local | 2022 | $24,434 | | tax credit/rebate |
Regeneron Pharmaceuticals, Inc. | Regeneron Pharmaceuticals | New York | local | 2022 | $22,434 | | tax credit/rebate |
Genentech Inc | Roche | Oregon | local | 2023 | $3,134,511 | | property tax abatement |
L. Perrigo Company | Perrigo | Michigan | local | 2021 | undisclosed | | property tax abatement |
Eli Lilly | Eli Lilly | Indiana | multiple | 1999 | $214,000,000 | | MEGADEAL |
Pfizer | Pfizer | Michigan | multiple | 2001 | $84,200,000 | | MEGADEAL (Archived) |
Amylin Pharmaceuticals | AstraZeneca | Ohio | multiple | 2007 | $117,000,000 | | MEGADEAL |
Pfizer | Pfizer | Connecticut | multiple | 1998 | $60,000,000 | | MEGADEAL (Archived) |
Vertex Pharmaceuticals | Vertex Pharmaceuticals | Massachusetts | multiple | 2011 | $72,000,000 | | MEGADEAL (Archived) |
AstraZeneca | AstraZeneca | Delaware | multiple | 1999 | $178,000,000 | | MEGADEAL |
Novo Nordisk | Novo Holdings A/S | North Carolina | multiple | 2016 | $109,900,000 | | MEGADEAL |
Elanco Animal Health Inc | Elanco Animal Health | Indiana | multiple | 2020 | $163,100,000 | | MEGADEAL |
Regeneron Pharmaceuticals | Regeneron Pharmaceuticals | New York | multiple | 2008 | $74,786,338 | | MEGADEAL (Archived) |
Regeneron Pharmaceuticals | Regeneron Pharmaceuticals | New York | multiple | 2021 | $107,700,000 | | MEGADEAL |
Regeneron Pharmaceuticals | Regeneron Pharmaceuticals | New York | multiple | 2018 | $155,700,000 | | MEGADEAL |
BIOSENSE WEBSTER, INC. | Johnson & Johnson | California | state | 2003 | $78,520 | | training reimbursement |
WATSON LABORATORIES, INC. | Teva Pharmaceutical Industries | California | state | 2003 | $166,452 | | training reimbursement |
NEUTROGENA CORPORATION | Johnson & Johnson | California | state | 2003 | $202,588 | | training reimbursement |
WATSON PHARMACEUTICALS, INC. | Teva Pharmaceutical Industries | California | state | 2005 | $32,240 | | training reimbursement |
DEY, L.P. | Viatris | California | state | 2005 | $121,613 | | training reimbursement |
IDEXX LABORATORIES, INC. | IDEXX Laboratories | California | state | 2006 | $36,530 | | training reimbursement |
VISX INCORPORATED | Abbott Laboratories | California | state | 2006 | $59,748 | | training reimbursement |
HOSPIRA, INC. | Pfizer | California | state | 2006 | $439,595 | | training reimbursement |
ABBOTT DIABETES CARE | Abbott Laboratories | California | state | 2007 | $359,454 | | training reimbursement |
GENENTECH, INC. | Roche | California | state | 2007 | $602,758 | | training reimbursement |
MILLIPORE, INC. | Merck KGaA (EMD) | California | state | 2009 | $1,440 | | training reimbursement |
MILLIPORE, INC. | Merck KGaA (EMD) | California | state | 2009 | $143,620 | | training reimbursement |
HOSPIRA, INC. | Pfizer | California | state | 2009 | $536,590 | | training reimbursement |
ABBOTT DIABETES CARE | Abbott Laboratories | California | state | 2010 | $843,336 | | training reimbursement |
ABBOTT VASCULAR, INC. | Abbott Laboratories | California | state | 2010 | $1,470,600 | | training reimbursement |
VISX, Inc | Abbott Laboratories | California | state | 2004 | undisclosed | | training reimbursement |
Hospira, Inc | Pfizer | California | state | 2007 | undisclosed | | training reimbursement |
Millipore, Inc. | Merck KGaA (EMD) | California | state | 2007 | undisclosed | | training reimbursement |
Millipore Corporation | Merck KGaA (EMD) | California | state | 2009 | undisclosed | | training reimbursement |
Protein Sciences Corporation/MEDCO | Sanofi | Connecticut | state | 1992 | $2,099,074 | | grant/loan hybrid program |
Purdue Pharma, LP | Purdue Pharma | Connecticut | state | 2001 | $3,000,000 | | grant/loan hybrid program |
Pfizer Central Research | Pfizer | Connecticut | state | 2000 | $5,000,000 | | grant |
Cambrex Charles City, Inc. | Cambrex | Iowa | state | 2006 | $165,000 | | grant/loan hybrid program |
Novartis Animal Health US, Inc. | Novartis | Iowa | state | 2007 | $500,000 | | grant/loan hybrid program |
Fort Dodge Laboratories, Inc. | Zoetis | Iowa | state | 2007 | $2,617,500 | | enterprise zone |
Abraxis BioScience | Bristol-Myers Squibb | Iowa | state | 2008 | $662,500 | | enterprise zone |
NewLink Genetics, Inc. | Lumos Pharma | Iowa | state | 2004 | $6,000,000 | | grant |
Fort Dodge Animal Health | Zoetis | Iowa | state | 2004 | $3,500,000 | | grant |
NewLink Genetics Corporation | Lumos Pharma | Iowa | state | 2004 | $414,200 | | tax credit/rebate |
Novartis Animal Health US, Inc. | Novartis | Iowa | state | 2007 | $466,425 | | tax credit/rebate |
Fort Dodge Animal Health | Zoetis | Iowa | state | 2004 | $1,975,500 | | tax credit/rebate |
Fort Dodge Animal Health | Zoetis | Iowa | state | 2004 | $1,000,000 | | infrastructure assistance |
Pfizer Inc & Subsidiaries | Pfizer | Iowa | state | 2010 | $942,184 | | tax credit/rebate |
Abraxis BioScience | Bristol-Myers Squibb | Iowa | state | 2008 | $400,000 | | grant/loan hybrid program |
Abbott Laboratories | Abbott Laboratories | Illinois | state | 2004 | undisclosed | | tax credit/rebate |
Hospira, Inc. and Subsidiaries | Pfizer | Illinois | state | 2004 | undisclosed | | tax credit/rebate |
Abbott Laboratories | Abbott Laboratories | Illinois | state | 2005 | $378,187 | | tax credit/rebate |
American Pharmaceutical Partners, Inc. | Bristol-Myers Squibb | Illinois | state | 2005 | undisclosed | | tax credit/rebate |
Hospira, Inc. and Subsidiaries | Pfizer | Illinois | state | 2005 | undisclosed | | tax credit/rebate |
Takeda Pharmaceuticals North America, Inc. | Takeda Pharmaceutical | Illinois | state | 2005 | undisclosed | | tax credit/rebate |
Abbott Laboratories | Abbott Laboratories | Illinois | state | 2006 | $381,909 | | tax credit/rebate |
Astellas US Holding, Inc. | Astellas Pharma | Illinois | state | 2006 | $1,060,334 | | tax credit/rebate |
Hospira, Inc. and Subsidiaries | Pfizer | Illinois | state | 2006 | undisclosed | | tax credit/rebate |
Takeda Pharmaceuticals North America, Inc. | Takeda Pharmaceutical | Illinois | state | 2006 | undisclosed | | tax credit/rebate |
Abbott Laboratories | Abbott Laboratories | Illinois | state | 2007 | $409,371 | | tax credit/rebate |
Astellas Research Institute of America | Astellas Pharma | Illinois | state | 2007 | undisclosed | | tax credit/rebate |
Astellas US Holding, Inc. | Astellas Pharma | Illinois | state | 2007 | $1,060,334 | | tax credit/rebate |
Hospira, Inc. and Subsidiaries | Pfizer | Illinois | state | 2007 | $1,385,605 | | tax credit/rebate |
Takeda Pharmaceuticals North America, Inc. | Takeda Pharmaceutical | Illinois | state | 2007 | undisclosed | | tax credit/rebate |
Abbott Laboratories | Abbott Laboratories | Illinois | state | 2008 | $485,631 | | tax credit/rebate |
Astellas Research Institute of America | Astellas Pharma | Illinois | state | 2008 | undisclosed | | tax credit/rebate |
Astellas US Holding, Inc. | Astellas Pharma | Illinois | state | 2008 | $1,605,983 | | tax credit/rebate |
Hospira, Inc. and Subsidiaries | Pfizer | Illinois | state | 2008 | $2,872,836 | | tax credit/rebate |
Takeda Pharmaceuticals North America, Inc. | Takeda Pharmaceutical | Illinois | state | 2008 | $2,034,824 | | tax credit/rebate |
Astellas Research Institute of America | Astellas Pharma | Illinois | state | 2009 | $62,980 | | tax credit/rebate |
Astellas US Holding, Inc. | Astellas Pharma | Illinois | state | 2009 | $1,605,983 | | tax credit/rebate |
Takeda Pharmaceuticals North America, Inc. | Takeda Pharmaceutical | Illinois | state | 2009 | $4,511,785 | | tax credit/rebate |
Astellas Research Institute of America | Astellas Pharma | Illinois | state | 2010 | $96,488 | | tax credit/rebate |
Astellas US Holding, Inc. | Astellas Pharma | Illinois | state | 2010 | $1,605,983 | | tax credit/rebate |
Lundbeck Inc. | Lundbeck | Illinois | state | 2010 | undisclosed | | tax credit/rebate |
Apotex Corporation | Apotex Corp. | Illinois | state | 2004 | $22,500 | | grant |
Astellas US Holding, Inc | Astellas Pharma | Illinois | state | 2005 | $137,500 | | grant |
Hospira, Inc. and Subsidiaries | Pfizer | Illinois | state | 2005 | $196,965 | | grant |
Hospira, Inc. and Subsidiaries | Pfizer | Illinois | state | 2005 | $196,965 | | grant |
Hospira, Inc. and Subsidiaries | Pfizer | Illinois | state | 2005 | $200,000 | | grant |
Hospira, Inc. and Subsidiaries | Pfizer | Illinois | state | 2005 | $200,000 | | grant |
Astellas US Holding, Inc | Astellas Pharma | Illinois | state | 2006 | $87,250 | | grant |
Takeda Pharmaceuticals North America, Inc. | Takeda Pharmaceutical | Illinois | state | 2006 | $350,000 | | grant |